Company: AEMD
Filing Date: 2025-09-09
Form Type: 8-K
Source: 0001683168-25-006788
Chunk: 3

Company: AETHLON MEDICAL INC
Filing Date: 2025-09-09
Form: 8-K
Item: Item 8.01
Chunk 3
---
Item 8.01 Other Events.

On September 4, 2025,
the Company issued a press release regarding the pricing of the Offering. A copy of the press release is furnished as Exhibit 99.1 hereto
and incorporated by reference.

Item 9.01 Financial Statements
and Exhibits.

(d) Exhibits

  Exhibit Number      Description                                                                                                                                                                                           
             4.1      Form of Common Warrant, dated September 4, 2025.                                                                                                                                                      
             4.2      Form of Pre-Funded Warrant, dated September 4, 2025.                                                                                                                                                  
             4.3      Placement Agent Warrant, dated September 4, 2025.                                                                                                                                                     
             4.4      Form of Warrant Agency Agreement by and between Aethlon Medical, Inc. and Computershare Inc. and its affiliate, Computershare Trust Company, N. A. (incorporated by reference to Form S-1/A filed on  
                      August 29, 2025 as Exhibit 4.13)                                                                                                                                                                      
            10.1      Form of Securities Purchase Agreement, dated September 4, 2025, by and between Aethlon Medical, Inc. and investors party thereto.                                                                     
            10.2      Placement Agency Agreement, dated September 4, 2025 by and between Aethlon Medical, Inc. and Maxim Group, LLC.                                                                                        
            99.1      Press Release, dated September 4, 2025.                                                                                                                                                               
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
             104      Cover Page Interactive Data File (embedded within the inline XBRL Document).                                                                                                                          

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  Date: September 9, 2025      Aethlon Medical, Inc.                                                           
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────
                               By:                        /s/ James B. Frakes                                  
                               Name:                      James B. Frakes                                      

   3